Dr. Karng S. Log
Claim this profileLutheran Hospital - Cancer Centers of Colorado
Studies Small Cell Lung Cancer
Studies Colon Cancer
10 reported clinical trials
32 drugs studied
Area of expertise
1Small Cell Lung Cancer
2Colon Cancer
Stage II
Stage III
MSS positive
Affiliated Hospitals
Clinical Trials Karng S. Log is currently running
Chemotherapy + Immunotherapy
for Esophageal and Gastric Cancer
This phase III trial compares the effect of modified fluorouracil, leucovorin calcium, oxaliplatin, and irinotecan (mFOLFIRINOX) to modified fluorouracil, leucovorin calcium, and oxaliplatin (mFOLFOX) for the treatment of advanced, unresectable, or metastatic HER2 negative esophageal, gastroesophageal junction, and gastric adenocarcinoma. The usual approach for patients is treatment with FOLFOX chemotherapy. Chemotherapy drugs work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Fluorouracil stops cells from making DNA and it may kill tumor cells. Leucovorin is used with fluorouracil to enhance the effects of the drug. Oxaliplatin works by killing, stopping, or slowing the growth of tumor cells. Some patients also receive an immunotherapy drug, nivolumab, in addition to FOLFOX chemotherapy. Immunotherapy may induce changes in body's immune system and may interfere with the ability of tumor cells to grow and spread. Irinotecan blocks certain enzymes needed for cell division and DNA repair, and it may kill tumor cells. Adding irinotecan to the FOLFOX regimen could shrink the cancer and extend the life of patients with advanced gastroesophageal cancers.
Recruiting2 awards Phase 32 criteria
Lomustine + Standard Therapy
for Glioblastoma
This phase III trial compares the effect of adding lomustine to standard chemotherapy with temozolomide and radiation therapy versus temozolomide and radiation therapy alone in shrinking or stabilizing newly diagnosed MGMT methylated glioblastoma. MGMT methylated tumors are more likely to respond to temozolomide chemotherapy. Temozolomide is in a class of medications called alkylating agents. It works by damaging the cell's DNA and may kill tumor cells and slow down or stop tumor growth. Lomustine is a chemotherapy drug and in a class of medications called alkylating agents. It damages the cell's DNA and may kill tumor cells. Radiation therapy uses high energy x-ray photons to kill tumor cells and shrink tumors. Adding lomustine to standard chemotherapy with temozolomide and radiation therapy may shrink or stabilize glioblastoma.
Recruiting2 awards Phase 34 criteria
More about Karng S. Log
Clinical Trial Related2 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Karng S. Log has experience with
- Oxaliplatin
- MFOLFIRINOX
- Carboplatin/Cisplatin-Etoposide
- HLX10
- Prophylactic Cranial Irradiation (PCI)
- Thoracic Radiotherapy
Breakdown of trials Karng S. Log has run
Small Cell Lung Cancer
Colon Cancer
Breast Cancer
Esophageal Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Karng S. Log specialize in?
Karng S. Log focuses on Small Cell Lung Cancer and Colon Cancer. In particular, much of their work with Small Cell Lung Cancer has involved treating patients, or patients who are undergoing treatment.
Is Karng S. Log currently recruiting for clinical trials?
Yes, Karng S. Log is currently recruiting for 5 clinical trials in Golden Colorado. If you're interested in participating, you should apply.
Are there any treatments that Karng S. Log has studied deeply?
Yes, Karng S. Log has studied treatments such as Oxaliplatin, mFOLFIRINOX, Carboplatin/Cisplatin-Etoposide.
What is the best way to schedule an appointment with Karng S. Log?
Apply for one of the trials that Karng S. Log is conducting.
What is the office address of Karng S. Log?
The office of Karng S. Log is located at: Lutheran Hospital - Cancer Centers of Colorado, Golden, Colorado 80401 United States. This is the address for their practice at the Lutheran Hospital - Cancer Centers of Colorado.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.